SynAct Pharma AB
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SynAct Pharma AB
The company’s lead candidate, AP1189, has shown promise in a mid-stage rheumatoid arthritis study, sparking plans for an imminent strategic business collaboration.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.